Expert perspectives on life sciences strategy, commercialization, and market dynamics.
Expert perspectives on life sciences strategy, commercialization, and market dynamics.
DURHAM, NC— Triangle Insights Group by Valeris (Triangle), a premier strategy consulting firm that delivers high-impact solutions across the life sciences value chain, has announced the appointment of Erin Solano to Partner. Solano is a seasoned life sciences executive who possesses strong analytical and communication skills responsible for driving meaningful commercial success for her clients. […]
The Inflation Reduction Act’s (IRA) Part D redesign provisions went into effect on January 1, 2025, fundamentally restructuring cost-sharing corridors and upsetting the marketplace. By increasing plan and manufacturer liability, particularly in the catastrophic phase, this legislation intended to lower the financial burden on beneficiaries. When the IRA passed, the commonly held hypothesis in the […]
In 2026, rare disease investors are prioritizing more than promising science. From commercial readiness to clear revenue pathways, expectations are shifting — and companies must evolve to secure funding and long-term growth.
Market access uncertainty is reshaping how life sciences companies forecast revenue and plan for launch. As pricing pressure, policy changes, and payer dynamics evolve, commercial teams must adopt more agile, data-driven forecasting strategies to stay competitive.
Planning a new product launch can be challenging. From assessing market needs to aligning cross-functional teams, companies must follow proven strategies to ensure a smooth, successful launch that meets commercial and compliance expectations.